Striatal Fast Spiking Interneurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Striatal Fast Spiking Interneurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
Striatal fast-spiking interneurons (FSIs) are parvalbumin-positive GABAergic [neurons](/entities/neurons) that provide powerful feedforward inhibition to medium spiny neurons. They coordinate striatal output and are critical for movement selection and motor learning. [@koos2004]
Striatal fast-spiking interneurons (FSIs) represent a critical inhibitory neuron population within the basal ganglia. These neurons provide powerful feedforward inhibition onto medium spiny neurons (MSNs) and other interneurons, shaping striatal output and motor learning. [@gittis2010]
Striatal FSIs are essential for proper basal ganglia function:
Feedforward Inhibition: FSIs receive excitatory inputs from cortical pyramidal neurons and thalamus, providing rapid inhibition onto MSNs.
Motor Sequencing: FSIs help orchestrate the precise timing of motor sequences by coordinating MSN activity.
Gain Control: They modulate the signal-to-noise ratio of corticostriatal inputs.
Gamma Oscillations: FSIs contribute to gamma-frequency oscillations important for sensorimotor integration.
Inhibition Timing: Their fast-spiking properties allow precise temporal control of inhibition.
Network Stability: FSIs prevent excessive excitation and maintain network stability.
Vulnerability in Disease
Huntington's Disease
FSIs show early and selective vulnerability in HD:
Progressive Degeneration: FSIs degenerate before MSNs in HD mouse models and human patients.
Motor Symptoms: FSI loss contributes to early motor abnormalities including chorea.
Circuit Dysfunction: Loss of FSI-mediated inhibition leads to hyperexcitability and alteredcortico-striatal plasticity.
Therapeutic Target: Preserving FSI function may slow HD progression.
Parkinson's Disease
Activity Changes: FSI firing patterns are altered in PD models.
Levodopa-Induced Dyskinesias: FSI dysfunction may contribute to LID development.
DBS Effects: Deep brain stimulation modulates FSI activity.
Alzheimer's Disease
Indirect Effects: While primarily affecting [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus), striatal FSIs may contribute to executive dysfunction in AD.
Transcriptomic Profile
Key genes expressed in striatal FSIs:
Therapeutic Implications
Biomarkers
PVALB Levels: CSF or blood parvalbumin may serve as biomarker for FSI integrity.
Neuroimaging: PET ligands targeting GABAergic neurons are under development.
Drug Development
GABAergic Agents: Modulating FSI activity may benefit HD and PD.
Potassium Channel Modulators: KCNJ2-targeted compounds could normalize FSI function.
Gene Therapy
Neuroprotective Factors: Delivering neurotrophic factors to FSIs may preserve their function.
Key Publications
Koos et al. (2021). Fast-spiking interneurons in the striatum. Nature Reviews Neuroscience, 22(8), 481-495.
Gittis et al. (2020). New insights into the role of striatal FSIs in motor learning. Neuron, 106(2), 189-192.
Cepeda et al. (2019). Striatal fast-spiking interneurons in Huntington's disease. Brain Pathology, 29(3), 370-384.
Kawaguchi et al. (2017). Physiological and morphological characterization of striatal FSIs. Journal of Neurophysiology, 118(4), 2214-2228.
Tepper et al. (2018). GABAergic interneurons of the striatum. Handbook of Behavioral Neuroscience, 27, 157-172.
Schmidt et al. (2020). FSI dysfunction in mouse models of [Parkinson's disease](/diseases/parkinsons-disease-disease). Journal of Neuroscience, 40(39), 7503-7518.
Plotkin et al. (2019). Impaired FSI function contributes to motor deficits in HD. Cell Reports, 29(11), 3492-3505.
Murer et al. (2017). The basal ganglia and striatal FSIs in health and disease. Progress in Brain Research, 235, 213-246.
The study of Striatal Fast Spiking Interneurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[@kawaguchi1995]: Kawaguchi Y et al. (1995). Striatal fast-spiking interneurons: physiological properties. Neuroscience. PMID: 7644022(https://pubmed.ncbi.nlm.nih.gov/7644022/) [@koos2004]: Koos T et al. (2004). Fast-spiking interneurons in the striatum. J Neurophysiol. PMID: 14749361(https://pubmed.ncbi.nlm.nih.gov/14749361/) [@gittis2010]: Gittis AH et al. (2010). Distinct roles of striatal fast-spiking interneurons. J Neurosci. PMID: 20926826(https://pubmed.ncbi.nlm.nih.gov/20926826/) [@tepper2010]: Tepper JM et al. (2010). GABAergic interneurons of the striatum. Prog Brain Res. PMID: 21094889(https://pubmed.ncbi.nlm.nih.gov/21094889/) [@planert2013]: Planert H et al. (2013). Synaptic integration of fast-spiking neurons in striatum. Cereb Cortex. PMID: 23196979(https://pubmed.ncbi.nlm.nih.gov/23196979/)